Terms: = Prostate cancer AND HSP90AA1, ENSG00000080824, 3320, P07900, LAP2, HSPN, HSPCAL4, HSPCAL1, HSPCA, HSPC1, HSP90N, HSP90A, Hsp90, Hsp89, HSP86, FLJ31884
292 results:
1. Combination of navitoclax (Bcl-2 and Bcl-xL inhibitor) and Debio-0932 (hsp90 inhibitor) suppresses the viability of prostate cancer cells via induction of apoptotic signaling pathway.
Asdemir A; Özgür A
Med Oncol; 2024 Mar; 41(4):83. PubMed ID: 38436810
[TBL] [Abstract] [Full Text] [Related]
2. Prospects and challenges of noncoding-RNA-mediated inhibition of heat shock protein 90 for cancer therapy.
Mattoo S; Gupta A; Chauhan M; Agrawal A; Pore SK
Biochim Biophys Acta Gene Regul Mech; 2024 Mar; 1867(1):195006. PubMed ID: 38218528
[TBL] [Abstract] [Full Text] [Related]
3. Antitumor Activity and Mechanism of Terpenoids in Seaweeds Based on Literature Review and Network Pharmacology.
Chen B; Li Y; Li W; Ye S; Zhu L; Ding Y
Adv Biol (Weinh); 2024 Mar; 8(3):e2300541. PubMed ID: 38134388
[TBL] [Abstract] [Full Text] [Related]
4. Efficient analysis of toxicity and mechanisms of environmental pollutants with network toxicology and molecular docking strategy: Acetyl tributyl citrate as an example.
Huang S
Sci Total Environ; 2023 Dec; 905():167904. PubMed ID: 37858827
[TBL] [Abstract] [Full Text] [Related]
5. Integrated transcriptome and proteome analysis indicates potential biomarkers of prostate cancer in offspring of pregnant rats exposed to a phthalate mixture during gestation and lactation.
Aquino AM; Alonso-Costa LG; Santos SAA; Rocha VA; Barbisan LF; Bedrat A; Justulin LA; Flaws JA; Lemos B; Scarano WR
Chemosphere; 2023 Nov; 341():140020. PubMed ID: 37690569
[TBL] [Abstract] [Full Text] [Related]
6. Capsaicin binds the N-terminus of hsp90, induces lysosomal degradation of Hsp70, and enhances the anti-tumor effects of 17-AAG (Tanespimycin).
Patwardhan CA; Kommalapati VK; Llbiyi T; Singh D; Alfa E; Horuzsko A; Korkaya H; Panda S; Reilly CA; Popik V; Chadli A
Sci Rep; 2023 Aug; 13(1):13790. PubMed ID: 37612326
[TBL] [Abstract] [Full Text] [Related]
7. Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer.
Bi W; Guo W; Fan G; Xie L; Jiang C
Aging (Albany NY); 2023 Jul; 15(14):7161-7186. PubMed ID: 37494663
[TBL] [Abstract] [Full Text] [Related]
8. An Overview of Recent Findings that Shed Light on the Connection between Fat and cancer.
Pandit P; Shirke C; Bhatia N; Godad A; Belemkar S; Patel J; Zine S
Endocr Metab Immune Disord Drug Targets; 2024; 24(2):178-193. PubMed ID: 37489790
[TBL] [Abstract] [Full Text] [Related]
9. Emodin-Induced Necroptosis in prostate cancer Cells via the Mitochondrial Fission hsp90/MLKL/PGAM Pathway.
Zhou X; Yeasmin Khusbu F; Xie Y; Yang P
Chem Biodivers; 2023 Jun; 20(6):e202201130. PubMed ID: 37062702
[TBL] [Abstract] [Full Text] [Related]
10. Stress-Inducible SCAND Factors Suppress the Stress Response and Are Biomarkers for Enhanced Prognosis in cancers.
Sheta M; Yoshida K; Kanemoto H; Calderwood SK; Eguchi T
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982267
[TBL] [Abstract] [Full Text] [Related]
11. Design, Synthesis, and Biological Evaluation of Androgen Receptor (AR) Antagonist-Heat Shock Protein 90 (hsp90) Inhibitor Conjugates for Targeted Therapy of Castration-Resistant prostate cancer.
Zhang S; Meng X; Zhang S; Li B; Jin W; Zhang C; Liu Z; Hu X; Ge L; Yu Z; Li Z; Ma S; Wang X; Li L; Qin C
J Med Chem; 2023 Apr; 66(7):4784-4801. PubMed ID: 36960664
[TBL] [Abstract] [Full Text] [Related]
12. Role of Ganetespib, an hsp90 Inhibitor, in cancer Therapy: From Molecular Mechanisms to Clinical Practice.
Youssef ME; Cavalu S; Hasan AM; Yahya G; Abd-Eldayem MA; Saber S
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902446
[TBL] [Abstract] [Full Text] [Related]
13. Protein Kinase D3 (PKD3) Requires hsp90 for Stability and Promotion of prostate cancer Cell Migration.
Varga A; Nguyen MT; Pénzes K; Bátai B; Gyulavári P; Gurbi B; Murányi J; Csermely P; Csala M; Vántus T; Sőti C
Cells; 2023 Jan; 12(2):. PubMed ID: 36672148
[TBL] [Abstract] [Full Text] [Related]
14. Risk of secondary tumours in patients with non-metastatic and metastatic human retinoblastoma.
Sadeghi R; Pirankuraim H; Javanshir ST; Arabi M; Bereimipour A; Javanshir HT; Mahmoodzadeh H; Nayernia K
Eye (Lond); 2023 Aug; 37(11):2327-2334. PubMed ID: 36528757
[TBL] [Abstract] [Full Text] [Related]
15. hsp90β inhibition upregulates interferon response and enhances immune checkpoint blockade therapy in murine tumors.
Rahmy S; Mishra SJ; Murphy S; Blagg BSJ; Lu X
Front Immunol; 2022; 13():1005045. PubMed ID: 36341371
[TBL] [Abstract] [Full Text] [Related]
16. Novel AR/AR-V7 and Mnk1/2 Degrader, VNPP433-3β: Molecular Mechanisms of Action and Efficacy in AR-Overexpressing Castration Resistant prostate cancer In Vitro and In Vivo Models.
Thomas E; Thankan RS; Purushottamachar P; Huang W; Kane MA; Zhang Y; Ambulos NP; Weber DJ; Njar VCO
Cells; 2022 Aug; 11(17):. PubMed ID: 36078112
[TBL] [Abstract] [Full Text] [Related]
17. Analysis of the multi-physiological and functional mechanism of wheat alkylresorcinols based on reverse molecular docking and network pharmacology.
Wei Y; Yu N; Wang Z; Hao Y; Wang Z; Yang Z; Liu J; Wang J
Food Funct; 2022 Aug; 13(17):9091-9107. PubMed ID: 35943408
[TBL] [Abstract] [Full Text] [Related]
18. Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer.
He T; Zhang Y; Li X; Liu C; Zhu G; Yin X; Zhang Z; Zhao K; Wang Z; Zhao P; Wang K
World J Surg Oncol; 2022 Jun; 20(1):174. PubMed ID: 35650630
[TBL] [Abstract] [Full Text] [Related]
19. HIF-1α and Nrf2 regulates hypoxia induced overexpression of DDAH1 through promoter activation in prostate cancer.
Parveen SMA; Natani S; Sruthi K K ; Khilar P; Ummanni R
Int J Biochem Cell Biol; 2022 Jun; 147():106232. PubMed ID: 35644470
[TBL] [Abstract] [Full Text] [Related]
20. Reduced HIF-1α Stability Induced by 6-Gingerol Inhibits Lung cancer Growth through the Induction of Cell Death.
Kim MJ; Ku JM; Choi YJ; Lee SY; Hong SH; Kim HI; Shin YC; Ko SG
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408505
[TBL] [Abstract] [Full Text] [Related]
[Next]